Inhibiting DNMT1 could suppress PCa development and activate the cytotoxic effects of CD8+ T cells by inhibiting the IGFBP2/EGFR/STAT3/PD-L1 pathway. The gene discussed is IGFBP2; the disease is posterior cortical atrophy.